Funding
← Back to your selection

Alexandria Venture Investments

Activity from announced rounds

Activity in this selectionSeries A
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$123M
3 disclosed · full round size, not this investor’s share

By stage

Series A3

By primary sector

Biotech3

By country

United States3

Rounds

3 in this selection
Leal Therapeutics

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries A
Role not disclosed
Fathom Therapeutics

Uses quantum chemistry and AI to design novel drug molecules

$47MSeries A
Role not disclosed